Myelodysplastic syndrome causes: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}} {{NM}} | {{CMG}};{{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
Common causes of myelodysplastic syndrome include genetic mutations.<ref name=cancergov2>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015</ref> | |||
==Causes== | ==Causes== | ||
=== | *Common causes of myelodysplastic syndrome include genetic mutations. | ||
===Primary Myelodysplastic syndrome=== | |||
* | *Approximately 90% of MDS cases occur de novo with no identifiable cause.<ref name=cancergov2>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015</ref> | ||
* | ===Secondary Myelodysplastic syndrome=== | ||
* | *Radiation | ||
* | *Benzene | ||
* | *Busulfan | ||
* | *Nitrosourea | ||
*Procarbazine | |||
*DNA topoisomerase inhibitors | |||
*Acquired aplastic anemia | |||
*Fanconi's anemia | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:39, 9 December 2015
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome causes On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome causes |
|
Risk calculators and risk factors for Myelodysplastic syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Common causes of myelodysplastic syndrome include genetic mutations.[1]
Causes
- Common causes of myelodysplastic syndrome include genetic mutations.
Primary Myelodysplastic syndrome
- Approximately 90% of MDS cases occur de novo with no identifiable cause.[1]
Secondary Myelodysplastic syndrome
- Radiation
- Benzene
- Busulfan
- Nitrosourea
- Procarbazine
- DNA topoisomerase inhibitors
- Acquired aplastic anemia
- Fanconi's anemia
References
- ↑ 1.0 1.1 Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015